ARCHIVES

NCI Budget of $1.4 Billion Seems Assured, Barring GRH Cut, Veto; Organ Systems Renewal Confirmed

This article is from The Cancer Letter archive.

Vol. 12 No. 40 | October 17, 1986

Download PDF Visit The Full Archive

Related Articles

EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure.

March 2, 2007

NIH To Fund Fewer Grants This Year, But Reduce Cuts to Individual Awards.

February 8, 2008

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

June 2, 2006

NCI Would Fund 1,052 Competing Grants In Fy95

February 11, 1994

Gallo, Rosenberg, Bishop, Varmus Win GM Awards

June 15, 1984

Roferon A Application Marred By Mission Data, Protocol, Compliance

September 24, 1999